Activities of New Fluoroquinolones, Ketolides, and Other Antimicrobials against Blood Culture Isolates of Viridans Group Streptococci from across Canada, 2000-Reference-Cited by-同舟云学术

Activities of New Fluoroquinolones, Ketolides, and Other Antimicrobials against Blood Culture Isolates of Viridans Group Streptococci from across Canada, 2000

Published:2002-05 Issue:5 Volume:46 Page:1553-1556
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Gershon Andrea S.¹,de Azavedo Joyce C. S.¹²,McGeer Allison¹²,Ostrowska Krystyna I.³,Church Deirdre⁴,Hoban Daryl J.⁵,Harding Godfrey K. M.⁶,Weiss Karl⁷,Abbott Lewis⁸,Smaill Fiona⁹,Gourdeau Marie¹⁰,Murray Gilles¹⁰,Low Donald E.²³

Affiliation:

1. University of Toronto

2. Toronto Medical Laboratories and Mount Sinai Hospital, Toronto

3. Trillium Health Centre, Mississauga

4. Calgary Laboratory Services, Calgary, Alberta

5. Health Sciences Centre

6. St. Boniface General Hospital, Winnipeg, Manitoba

7. Hopital Maisonneuve-Rosemont, University of Montreal, Montreal

8. Queen Elizabeth Hospital, Charlottetown, Prince Edward Island, Canada

9. Hamilton Health Sciences Centre, Hamilton, Ontario

10. Hopital de l'Enfant-Jesus, Quebec City, Quebec

Abstract

ABSTRACT The rates of nonsusceptibility to penicillin, erythromycin, and clindamycin of 191 blood culture isolates of viridans group streptococci collected from across Canada in 2000 were 36, 42, and 10%, respectively. Although 8% of the strains were resistant to ciprofloxacin (MIC ⩾ 4 μg/ml), the MICs of gemifloxacin, BMS 284756, telithromycin, and ABT 773 at which 90% of the strains were inhibited were 0.06, 0.06, 0.12, and 0.03 μg/ml, respectively.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.46.5.1553-1556.2002

Reference22 articles.

1. Carratala, J., F. Alcaide, A. Fernandez-Sevilla, X. Corbella, J. Linares, and F. Gudiol. 1995. Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer. Clin. Infect. Dis.20:1169-1173.

2. In Vitro Activities of Fluoroquinolones against Antibiotic-Resistant Blood Culture Isolates of Viridans Group Streptococci from across Canada

3. Prevalence and Mechanisms of Macrolide Resistance in Clinical Isolates of Group A Streptococci from Ontario, Canada

4. Diekema, D. J., M. L. Beach, M. A. Pfaller, and R. N. Jones. 2001. Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America. Clin. Microbiol. Infect.7:152-157.

5. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical features and antimicrobial susceptibility of oral bacteria isolated from the blood cultures of patients with infective endocarditis;Journal of Dental Sciences;2021-09

2. Antibiotic Resistance of Viridans Group Streptococci Isolated from Dental Plaques;Biocontrol Science;2020

3. Periodontitis, Bacteremia and Infective Endocarditis: A Review Study;Archives of Pediatric Infectious Diseases;2017-01-16

4. Antibiotic Resistance of Non-pneumococcal Streptococci and Its Clinical Impact;Antimicrobial Drug Resistance;2017

5. Quinolone Resistance and Its Clinical Relevance;Quinolone Antimicrobial Agents;2014-04-08